Meeting
2024 ASCO Gastrointestinal Cancers Symposium
Real-world testing, treatment patterns, and outcomes following liquid biopsy in advanced cholangiocarcinoma.
Authors
Amit Mahipal
University Hospitals Cleveland Medical Center, Cleveland, OH
Amit Mahipal , Keelia M. Clemens , Jiemin Liao , Caroline M. Weipert , Leslie Bucheit , Moh'd M. Khushman
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Patient-Reported Outcomes and Real-World Evidence
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 455)
DOI
10.1200/JCO.2024.42.3_suppl.455
Abstract #
455
Poster Bd #
A20
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
Profiling of 3,634 cholangiocarcinomas (CCA) to identify genomic alterations (GA), tumor mutational burden (TMB), and genomic loss of heterozygosity (gLOH).
First Author: Milind M. Javle
Poster
2018 ASCO Annual Meeting
Impact of cholangiocarcinoma (CC) molecular heterogeneity on outcome during first-line chemotherapy and access to targeted therapies in early clinical trials (CT).
First Author: Helena Verdaguer
Poster
2017 Gastrointestinal Cancers Symposium
Parallel sequencing of a 50 genes panel in metastatic colorectal cancer (MCRC) patients (pts) treated with intensive first-line FIr-B/FOx triplet chemotherapy plus bevacizumab (BEV): Preliminary data and clinical outcome.
First Author: Gemma Bruera
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Incidence and prognostic value of actionable mutations in early-stage resectable cholangiocarcinoma.
First Author: Kailey Morgan Oppat